| 3.535 -0.18 (-4.85%) | 10-08 12:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.86 |
1-year : | 5.44 |
| Resists | First : | 4.16 |
Second : | 4.65 |
| Pivot price | 3.87 |
|||
| Supports | First : | 3.37 |
Second : | 2.8 |
| MAs | MA(5) : | 3.65 |
MA(20) : | 3.91 |
| MA(100) : | 4.51 |
MA(250) : | 7.16 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 21.6 |
D(3) : | 23.2  |
| RSI | RSI(14): 31 |
|||
| 52-week | High : | 20.2 | Low : | 3.37 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TLRY ] has closed above bottom band by 4.1%. Bollinger Bands are 22.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.76 - 3.78 | 3.78 - 3.8 |
| Low: | 3.66 - 3.68 | 3.68 - 3.7 |
| Close: | 3.68 - 3.72 | 3.72 - 3.74 |
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Thu, 08 Oct 2026
Tilray Brands Q1 Earnings Call Highlights - Yahoo Finance
Thu, 08 Oct 2026
Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines - Benzinga
Thu, 08 Oct 2026
Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines - TradingView
Thu, 08 Oct 2026
Tilray Brands Q1 2027 Earnings Call Transcript - Benzinga
Thu, 08 Oct 2026
Tilray Brands (TLRY) Shares Slip Premarket After Q1 Revenue Miss Despite Growth - GuruFocus
Thu, 08 Oct 2026
Tilray Brands (TLRY) Posts Mixed Q1 Results Amid New 52-Week Low and Regulatory Pause - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 138 (M) |
| Shares Float | 437 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 10.9 (%) |
| Shares Short | 18,430 (K) |
| Shares Short P.Month | 16,230 (K) |
| EPS | -1.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.01 |
| Profit Margin | -13.3 % |
| Operating Margin | -52.8 % |
| Return on Assets (ttm) | -1.5 % |
| Return on Equity (ttm) | -6.9 % |
| Qtrly Rev. Growth | -7.9 % |
| Gross Profit (p.s.) | 1.9 |
| Sales Per Share | 6.65 |
| EBITDA (p.s.) | 0.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -69 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -3.18 |
| PEG Ratio | 0 |
| Price to Book value | 1.14 |
| Price to Sales | 0.52 |
| Price to Cash Flow | -6.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|